Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



Elasmogen Receives £1.2m In Grant And Equity Investment

Elasmogen Ltd, developer of soloMERTM biologics, today announced that it has received a Biomedical Catalyst Grant from the UK’s innovation agency, Innovate UK and matching investment from Deepbridge Capital and Scottish Investment Bank (the investment arm of Scottish Enterprise) totalling £1.2 M. The funding will be used to develop ELN-21 and ELN-22, the companies’ next generation biologics for topical treatment of ocular disease.

Read the rest of entry »

Summit to Extend Ongoing PhaseOut DMD Clinical Trial of Ezutromid in Patients with DMD

Oxford, UK, 27 March 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and Clostridium difficile infection, announces that it will proceed with the planned extension phase of PhaseOut DMD, a Phase 2 clinical trial evaluating the utrophin modulator ezutromid, subject to regulatory approval. This follows an interim review of the safety and tolerability data from the ongoing trial by an independent Data Monitoring Committee ('DMC') and its support of Summit's plans to extend the clinical trial.

Read the rest of entry »

Oxford Immunotec Announces Release of New National Tuberculosis Test Data and Screening Grant for High Risk Patients on World TB Day

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 23, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced the release of national T-SPOT®.TB test positivity rates within the United States and United Kingdom, as well as a grant to support TB screening for high risk patients.

Read the rest of entry »

SRG launches 2017 Salary Survey in conjunction with New Scientist

Discussing the latest salary and market trends in the science industry, the report is based on over 3,000 responses from SRG’s global database and the readership of New Scientist magazine.

Read the rest of entry »

The UK's 2017 Spring Budget - Potential Impact on the UK Biotech Industry

Oxford, UK - The Spring Budget delivered by the Chancellor on 8 March 2017 continues to hit the headlines.  What is its potential impact on the UK biotech industry?

Read the rest of entry »

Wickham Labs to Exhibit at Making Pharmaceuticals 2017

Wickham Laboratories Ltd will exhibit on Stand 309 at the Making Pharmaceuticals Conference on the 25th – 26th April 2017 at Ricoh Arena, Coventry.

Read the rest of entry »

Important Milestone Achieved by Isansys Aiming to Improve Monitoring and Save Lives

Abingdon, UK - Patient Status Engine and Lifetouch™ ‘smart bandage’ technology has now monitored more than 1,000 patients in a ground-breaking project transforming the way young patients are cared for.  A ground-breaking project at Birmingham Children’s Hospital using wireless technology to predict deterioration in seriously ill children has recruited its 1,000th patient.

Read the rest of entry »

Isansys Lifecare Hires New UK Sales Manager

Abingdon, UK: Isansys Lifecare, the market leader in new generation wireless patient monitoring technology and patient digitisation systems and services, today announced the hiring of Sam Thwaites as its new UK Sales Manager, reporting to CEO Keith Errey.

Read the rest of entry »

High Purity Reagents for Proteoglycan & Glycosaminoglycan Research

Abingdon, UK - AMSBIO has published a new 36-page catalogue that details its comprehensive range of high purity reagents for proteoglycan and glycosaminoglycan research.

Read the rest of entry »

Isansys Lifecare Granted Key Patent for Its Innovative Patient Monitoring Platform

Abingdon, UK – Isansys Lifecare, a digital healthcare company developing an innovative patient monitoring platform which enables the early detection of deterioration in patients, today announces that the European Patent Office has accepted for grant a key method patent. The patent relates to the wireless wearable sensor technology incorporated in the Patient Status Engine (PSE), a CE-marked, Class IIa, continuous multiple vital sign patient monitoring platform.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.

Don't forget about the 'wandering kitchens' near No. 99 on Milton Park on Thursday lunchtime!